Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Antimetastatic and Antitumorigenic Effects in Endometrial Cancer

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2014.03.297
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Anti-Metastatic and Anti-Tumorigenic Effects in Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2014English

Pitavastatin, an HMG-CoA Reductase Inhibitor, Ameliorates Endothelial Function in Chronic Smokers

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Effects of an HMG-CoA Reductase Inhibitor on Cytokine Production by Human Monocytes/Macrophages.

Journal of Nippon Medical School
1995English

Characterization of an HMG-CoA Reductase From Listeria Monocytogenes That Exhibits Dual Coenzyme Specificity

English

Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia

The Journal of Japan Atherosclerosis Society
2002English

Pleiotropic Effects of the HMG-CoA Reductase Inhibitors

International Journal of General Medicine
Medicine
2011English

HMG-CoA Reductase Inhibitor Simvastatin Mitigates VEGF-induced "Inside-Out" Signaling to Extracellular Matrix by Preventing RhoA Activation

AJP: Renal Physiology
2006English

Fluvastatin, an HMG-CoA Reductase Inhibitor, Protects LDL From Oxidative Modification in Hypercholesterolemic Rabbits.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2000English

Mechanism of HMG-CoA Reductase Inhibitor-Induced Contractile Dysfunction in Rat Cultured Skeletal Muscle

Biophysical Journal
Biophysics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy